Position in NVS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$7,585,248
+$100,498 QoQ
Shares Held
48,400
-1.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#205
of 1,603 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LOCKHEED MARTIN INVESTMENT MANAGEMENT CO holds $85,820,334 across 7 Drug Manufacturers - General names. NVS ranks #4 (8.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
171,210 | $43,482,203 | |
| 2 | LLY |
ELI LILLY & Co
|
13,090 | $15,700,540 | |
| 3 | ABBV |
AbbVie Inc.
|
41,130 | $10,349,953 | |
| 4 | NVS |
Novartis AG
This page
|
48,400 | $7,585,248 | |
| 5 | MRK |
Merck & Co., Inc.
|
32,500 | $4,176,250 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
24,100 | $3,044,794 | |
| 7 | NVO |
Novo Nordisk A S
|
30,900 | $1,481,346 |
All Filings in NVS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,585,248 | 48,400 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $7,484,750 | 49,000 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $7,899,951 | 57,300 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $10,926,048 | 85,200 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $8,918,437 | 73,700 | Shares | Sole | 2025-08-04 | |
| No filing history on record for this holder in this stock. | ||||||